6HDO
Crystal structure of human ATAD2 bromodomain in complex with 8-(((1R,2R,3R,5S)-2-(2-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)ethyl)-8-azabicyclo[3.2.1]octan-3-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)quinolin-2(1H)-one
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU FR-E SUPERBRIGHT |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-10-22 |
Detector | RIGAKU SATURN A200 |
Wavelength(s) | 1.54178 |
Spacegroup name | P 65 2 2 |
Unit cell lengths | 79.254, 79.254, 135.033 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 37.640 - 2.610 |
R-factor | 0.18646 |
Rwork | 0.184 |
R-free | 0.23194 |
RMSD bond length | 0.015 |
RMSD bond angle | 1.480 |
Data reduction software | XDS |
Data scaling software | SCALA |
Refinement software | REFMAC (5.8.0073) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 135.030 | 2.750 |
High resolution limit [Å] | 2.610 | 2.610 |
Number of reflections | 8153 | |
<I/σ(I)> | 20.8 | |
Completeness [%] | 99.6 | 100 |
Redundancy | 10.3 | 10.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 277 | 0.1M trisHCl pH 7.0-8.0, 1.2-1.5M ammonium sulphate and 20-25% PEG3350 |